Precursor Cell Lymphoblastic Leukemia Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
879
|
168
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Forced expiratory volume function
|
phenotype |
|
Organ or Tissue Function
|
272
|
1169
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Glomerular Filtration Rate
|
phenotype |
|
Diagnostic Procedure
|
399
|
1033
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Juvenile arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
450
|
128
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Nasopharyngeal carcinoma
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
1553
|
320
|
0.100 |
None |
1.000 |
1 |
2
|
2010 |
2010 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
145
|
21
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3
|
disease |
|
Finding
|
578
|
1158
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.040 |
None |
1.000 |
4 |
2
|
2011 |
2019 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.040 |
None |
1.000 |
4 |
|
2015 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.030 |
None |
1.000 |
3 |
1
|
2014 |
2016 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.030 |
None |
1.000 |
3 |
1
|
2014 |
2016 |
Gastrointestinal Stromal Tumors
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
538
|
154
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Childhood Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2527
|
98
|
0.020 |
None |
1.000 |
2 |
1
|
2011 |
2014 |
Adult Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2528
|
98
|
0.020 |
None |
1.000 |
2 |
1
|
2011 |
2014 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2016 |
Chromosome 10, monosomy 10q
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
16
|
4
|
0.010 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Respiratory Distress Syndrome
|
disease |
|
Disease or Syndrome
|
58
|
9
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adult Oligodendroglial Tumor
|
disease |
|
Neoplastic Process
|
14
|
2
|
0.010 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Oligodendroglial Neoplasm
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
14
|
2
|
0.010 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Low grade glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
85
|
10
|
0.010 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Respiratory distress
|
phenotype |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases
|
Sign or Symptom
|
259
|
16
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Acute monocytic leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
633
|
22
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Anemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
847
|
94
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |